We scan new podcasts and send you the top 5 insights daily.
Effective review boards don't just say yes or no. They ask, "What is the next experiment needed to secure the next round of funding?" This approach relies on micro-budgeting for specific tests and regularly rotating board members to prevent political capture and groupthink.
To prevent review meetings from becoming about personal opinions, enforce a rule: all criticism must be linked to a testable hypothesis or a clear gap in existing data. This transforms subjective feedback into an objective, evidence-based discussion about what needs to be validated next.
In ROI-focused cultures like financial services, protect innovation by dedicating a formal budget (e.g., 20% of team bandwidth) to experiments. These initiatives are explicitly exempt from the rigorous ROI calculations applied to the rest of the roadmap, which fosters necessary risk-taking.
To improve decision-making, BlackRock's investment committee, guided by a behavioral scientist, uses autonomous voting to prevent peer pressure. It also mandates a non-voting "challenger" to play devil's advocate and champion a pre-mortem perspective, ensuring dissent is valued.
Early-stage ideas are easily killed by practical objections. To prevent this, implement a rule where feedback must begin with "Yes, and...". This forces critics to be additive and constructive, building upon the initial concept rather than immediately shutting it down. It creates space for a bold idea to develop before facing harsh reality checks.
When facing internal resistance to a big idea, the tendency is to make the idea smaller and safer. The better approach is to protect the ambitious vision but shrink the steps to validate it, using small, targeted experiments to build evidence and momentum.
Treat government programs as experiments. Define success metrics upfront and set a firm deadline. If the program fails to achieve its stated goals by that date, it should be automatically disbanded rather than being given more funding. This enforces accountability.
In biotech, early data is often ambiguous. Instead of judging programs on potential, leaders must prioritize based on the time and capital required to reach a clear 'yes' or 'no' outcome. Indefinite 'gray zone' projects drain resources that could fund a winner.
While intended to kill bad ideas, review committees are often populated by executives who remain in place permanently. They use the board to make numerous small bets, claiming victory for the few that succeed while blaming others for failures. This behavior prioritizes personal prestige over sound investment strategy.
To get a major initiative approved, don't just pitch the vision. Interview key decision-makers beforehand and ask for every possible objection. Then, build your pitch around a mitigation plan for each concern, removing every reason for them to say 'no' before you even formally present.
Enforce a strict separation between who provides input and who makes the decision. Input should be broad (customers, data, stakeholders), but the decision must be singular and accountable. When the input group is also the decision group, you get a committee that optimizes for safety, not outcomes.